Aurobindo Pharma gets FTC nod for $250 million Lannett buyout, deal to boost US manufacturing capacity to 4 billion doses

The trace

How it reaches your house.

Starting from the trigger, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.

The causal trace for this event is still being written.